Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Performance of three rapid antigen tests against the SARS-CoV-2 Omicron variant

View ORCID ProfileSanjat Kanjilal, View ORCID ProfileSujata Chalise, View ORCID ProfileAdnan Shami Shah, View ORCID ProfileChi-An Cheng, View ORCID ProfileYasmeen Senussi, View ORCID ProfileRockib Uddin, Vamsi Thiriveedhi, Ha Eun Cho, Seamus Carroll, View ORCID ProfileJacob Lemieux, View ORCID ProfileSarah Turbett, View ORCID ProfileDavid R Walt
doi: https://doi.org/10.1101/2022.02.17.22271142
Sanjat Kanjilal
1Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, MA
2Department of Pathology, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sanjat Kanjilal
  • For correspondence: skanjilal@bwh.harvard.edu
Sujata Chalise
2Department of Pathology, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA
3Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sujata Chalise
Adnan Shami Shah
2Department of Pathology, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA
3Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adnan Shami Shah
Chi-An Cheng
2Department of Pathology, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA
3Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chi-An Cheng
Yasmeen Senussi
2Department of Pathology, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA
3Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yasmeen Senussi
Rockib Uddin
4Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rockib Uddin
Vamsi Thiriveedhi
4Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ha Eun Cho
4Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seamus Carroll
4Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob Lemieux
4Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jacob Lemieux
Sarah Turbett
4Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah Turbett
David R Walt
2Department of Pathology, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA
3Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David R Walt
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Rapid antigen detection tests (RADTs) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now in widespread use in the United States. RADTs play an important role in maintaining an open society but require periodic reassessment to ensure test performance remains intact as the virus evolves. The nucleocapsid (N) protein is the target for the majority of RADTs and the SARS-CoV-2 Omicron variant has several N protein mutations that are previously uncharacterized. We sought to assess the impact of these mutations by testing 30 Omicron variant samples across a wide range of viral loads on three widely used RADTs: the iHealth COVID-19 Antigen Rapid Test, the ACON Laboratories FlowFlex COVID-19 Antigen Home Test, and the Abbott BinaxNOW COVID-19 Antigen Card, using 30 Delta variant samples as a comparator. We found no change in the analytic sensitivity of all three RADTs for detection of Omicron versus Delta, but noted differences in performance between assays. No RADT was able to detect samples with a cycle threshold (Ct) value of ≥27.5 for the envelope gene target on the Roche cobas RT-PCR assay. Epidemiologic studies are necessary to correlate these findings with their real-world performance.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by a grant from the Massachusetts Consortium for Pathogen Readiness.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was deemed non-human subjects research and approved by the Mass General Brigham Institutional Review Board (protocol 2021P003604).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted February 19, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Performance of three rapid antigen tests against the SARS-CoV-2 Omicron variant
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Performance of three rapid antigen tests against the SARS-CoV-2 Omicron variant
Sanjat Kanjilal, Sujata Chalise, Adnan Shami Shah, Chi-An Cheng, Yasmeen Senussi, Rockib Uddin, Vamsi Thiriveedhi, Ha Eun Cho, Seamus Carroll, Jacob Lemieux, Sarah Turbett, David R Walt
medRxiv 2022.02.17.22271142; doi: https://doi.org/10.1101/2022.02.17.22271142
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Performance of three rapid antigen tests against the SARS-CoV-2 Omicron variant
Sanjat Kanjilal, Sujata Chalise, Adnan Shami Shah, Chi-An Cheng, Yasmeen Senussi, Rockib Uddin, Vamsi Thiriveedhi, Ha Eun Cho, Seamus Carroll, Jacob Lemieux, Sarah Turbett, David R Walt
medRxiv 2022.02.17.22271142; doi: https://doi.org/10.1101/2022.02.17.22271142

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9004)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1962)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1330)
  • Health Policy (662)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10826)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1837)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1003)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (582)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4133)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)